InsidersTradesSigma
Follow the RedHill Biopharma Ltd. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.7m. The latest transaction was reported on 13 July 2026 (Cession). Among the most active insiders: Raday Gilead. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
RedHill Biopharma Ltd. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases. It is listed on NASDAQ under the ticker RDHL.